FDA orphan drug designation: treatment of acute myeloid leukemia
All entries for: Akeso Biopharma Co. Ltd
September 11, 2025
Akeso Biopharma Co. Ltd
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of acute myeloid leukemia
